RDY
Dr. Reddy’s Laboratories Ltd ADRNYSEHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$11.31B
P/E Ratio
26.06
EPS
$0.52
Beta
0.29
52W High
$16.07
52W Low
$12.19
50-Day MA
$13.48
200-Day MA
$13.92
Dividend Yield
0.62%
Profit Margin
12.80%
Forward P/E
25.45
PEG Ratio
3.80
About Dr. Reddy’s Laboratories Ltd ADR
Dr. Reddy's Laboratories Limited is a globally integrated pharmaceutical company. The company is headquartered in Hyderabad, India.
Fundamentals
| Revenue (TTM) | $335.93B |
| Gross Profit (TTM) | $177.26B |
| EBITDA | $70.51B |
| Operating Margin | 5.20% |
| Return on Equity | 11.80% |
| Return on Assets | 5.82% |
| Revenue/Share (TTM) | $67.40 |
| Book Value | $0.79 |
| Price-to-Book | 2.89 |
| Price-to-Sales (TTM) | 0.03 |
| EV/Revenue | 3.236 |
| EV/EBITDA | 13.89 |
| Quarterly Earnings Growth (YoY) | -86.20% |
| Quarterly Revenue Growth (YoY) | -11.60% |
| Shares Outstanding | $832.60M |
| Float | $600.30M |
| % Insiders | 0.00% |
| % Institutions | 15.11% |
Historical Volatility
HV 10-Day
42.27%
HV 20-Day
34.05%
HV 30-Day
34.32%
HV 60-Day
29.64%
HV Rank
98.0%
Volatility is currently expanding
Analyst Ratings
Consensus ($14.16 target)
2
Buy2
Hold1
SellMore HEALTHCARE Stocks
Data last updated: 5/23/2026